These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3755306

  • 1. Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination.
    Fisher DM, Canfell PC, Fahey MR, Rosen JI, Rupp SM, Sheiner LB, Miller RD.
    Anesthesiology; 1986 Jul; 65(1):6-12. PubMed ID: 3755306
    [Abstract] [Full Text] [Related]

  • 2. The in vitro degradation of cisatracurium, the R, cis-R'-isomer of atracurium, in human and rat plasma.
    Welch RM, Brown A, Ravitch J, Dahl R.
    Clin Pharmacol Ther; 1995 Aug; 58(2):132-42. PubMed ID: 7648763
    [Abstract] [Full Text] [Related]

  • 3. Metabolism and kinetics of atracurium: an overview.
    Neill EA, Chapple DJ, Thompson CW.
    Br J Anaesth; 1983 Aug; 55 Suppl 1():23S-25S. PubMed ID: 6688012
    [Abstract] [Full Text] [Related]

  • 4. Importance of the organ-independent elimination of cisatracurium.
    Kisor DF, Schmith VD, Wargin WA, Lien CA, Ornstein E, Cook DR.
    Anesth Analg; 1996 Nov; 83(5):1065-71. PubMed ID: 8895287
    [Abstract] [Full Text] [Related]

  • 5. [Metabolism and pharmacokinetics of atracurium].
    Colin JN, Singlas E.
    Ann Fr Anesth Reanim; 1985 Nov; 4(6):465-70. PubMed ID: 2936284
    [Abstract] [Full Text] [Related]

  • 6. Inactivation of atracurium in human and rat plasma.
    Nigrovic V, Pandya JB, Auen M, Wajskol A.
    Anesth Analg; 1985 Nov; 64(11):1047-52. PubMed ID: 2932037
    [Abstract] [Full Text] [Related]

  • 7. Enzymatic hydrolysis of atracurium in vivo.
    Nigrovic V, Auen M, Wajskol A.
    Anesthesiology; 1985 May; 62(5):606-9. PubMed ID: 3838864
    [Abstract] [Full Text] [Related]

  • 8. Atracurium: conception and inception.
    Stenlake JB, Waigh RD, Urwin J, Dewar GH, Coker GG.
    Br J Anaesth; 1983 May; 55 Suppl 1():3S-10S. PubMed ID: 6688014
    [Abstract] [Full Text] [Related]

  • 9. Studies on the pharmacokinetics of cisatracurium in anesthetized dogs: in vitro-in vivo correlations.
    Chen C, Yamaguchi N, Varin F.
    J Vet Pharmacol Ther; 2009 Dec; 32(6):571-6. PubMed ID: 20444012
    [Abstract] [Full Text] [Related]

  • 10. Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant.
    Basta SJ, Ali HH, Savarese JJ, Sunder N, Gionfriddo M, Cloutier G, Lineberry C, Cato AE.
    Anesth Analg; 1982 Sep; 61(9):723-9. PubMed ID: 6213181
    [Abstract] [Full Text] [Related]

  • 11. Clinical pharmacokinetics of cisatracurium besilate.
    Kisor DF, Schmith VD.
    Clin Pharmacokinet; 1999 Jan; 36(1):27-40. PubMed ID: 9989341
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic modelling of a parent drug and its metabolite. Atracurium and laudanosine.
    Nigrovic V, Banoub M.
    Clin Pharmacokinet; 1992 May; 22(5):396-408. PubMed ID: 1505145
    [Abstract] [Full Text] [Related]

  • 13. Cumulative characteristics of atracurium and vecuronium. A simultaneous clinical and pharmacokinetic study.
    Wright PM, Hart P, Lau M, Sharma ML, Gruenke L, Fisher DM.
    Anesthesiology; 1994 Jul; 81(1):59-68; discussion 27A. PubMed ID: 7913801
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and pharmacodynamics of the benzylisoquinolinium muscle relaxants.
    Hull CJ.
    Acta Anaesthesiol Scand Suppl; 1995 Jul; 106():13-7. PubMed ID: 8533537
    [Abstract] [Full Text] [Related]

  • 15. Influence of incubated atracurium on rat liver function.
    Burgmann H, Reckendorfer H, Sperlich M, Tüchy GL, Spieckermann PG, Weindlmayr-Göttel M, Schwarz S.
    Br J Anaesth; 1994 Mar; 72(3):324-7. PubMed ID: 8130052
    [Abstract] [Full Text] [Related]

  • 16. Assuming peripheral elimination: its impact on the estimation of pharmacokinetic parameters of muscle relaxants.
    Laurin J, Nekka F, Donati F, Varin F.
    J Pharmacokinet Biopharm; 1999 Oct; 27(5):491-512. PubMed ID: 10948695
    [Abstract] [Full Text] [Related]

  • 17. Does ester hydrolysis change the in vitro degradation rate of cisatracurium and atracurium?
    Weindlmayr-Goettel M, Gilly H, Kress HG.
    Br J Anaesth; 2002 Apr; 88(4):555-62. PubMed ID: 12066733
    [Abstract] [Full Text] [Related]

  • 18. In vitro degradation of atracurium in human plasma.
    Stiller RL, Cook DR, Chakravorti S.
    Br J Anaesth; 1985 Nov; 57(11):1085-8. PubMed ID: 3840382
    [Abstract] [Full Text] [Related]

  • 19. Atracurium decay and the formation of laudanosine in humans.
    Nigrovic V, Fox JL.
    Anesthesiology; 1991 Mar; 74(3):446-54. PubMed ID: 2001023
    [Abstract] [Full Text] [Related]

  • 20. In vitro degradation of atracurium and cisatracurium at pH 7.4 and 37 degrees C depends on the composition of the incubating solutions.
    Weindlmayr-Goettel M, Kress HG, Hammerschmidt F, Nigrovic V.
    Br J Anaesth; 1998 Sep; 81(3):409-14. PubMed ID: 9861132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.